The Real Stakes of Phase 2: You Cannot Afford to Wait
Phase 2 is the ultimate "make or break" moment for drug development and why cutting corners now leads to catastrophic failure later. This Guard Rail blog breaks down the essential risk-mitigation strategies needed to bridge the treacherous gap between initial proof of concept and a successful Phase 3 trial.
The Green Tea Matrix: Evaluating Caffeine Concentration and Its Interactions
This week in the Guardrail, we explore the pharmacological profile of green tea, specifically examining how its modest caffeine content interacts with unique compounds like L-theanine. Read more for essential insights into the drink's distinctive stimulant effects and metabolic influence.
Clinical Trial Optimization
Clinical trials are the backbone of drug development. They provide the evidence needed to show that a product is safe and effective. They also represent one of the largest investments a pharmaceutical company will make